bioRxivMicrobiology
An emerging SARS-CoV-2 mutant evading cellular immunity and increasing viral infectivity
C. Motozono, M. Toyoda, J. Zahradnik, T. Ikeda, A. Saito, T. S. Tan, I. Ngare, H. Nasser, I. Kimura, K. Uriu, Y. Kosugi, S. Torii, A. Yonekawa, N. Shimono, Y. Nagasaki, R. Minami, T. Toya, N. Sekiya, T. Fukuhara, Y. Matsuura, G. Schreiber, The Genotype to Phenotype Japan (G2P-Japan) consortium, S. Nakagawa, T. Ueno, K. Sato
Abstract
During the current SARS-CoV-2 pandemic that is devastating the modern societies worldwide, many variants that naturally acquire multiple mutations have emerged. Emerging mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has recently been investigated, that to human leukocyte antigen (HLA)-restricted cellular immunity remains unaddressed. Here we demonstrate that two recently emerging mutants in the receptor binding domain of the SARS-CoV-2 spike protein, L452R (in B.1.427/429) and Y453F (in B.1.298), can escape from the HLA-24-restricted cellular immunity. These mutations reinforce the affinity to viral receptor ACE2, and notably, the L452R mutation increases protein stability, viral infectivity, and potentially promotes viral replication. Our data suggest that the HLA-restricted cellular immunity potentially affects the evolution of viral phenotypes, and the escape from cellular immunity can be a further threat of the SARS-CoV-2 pandemic. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=198 SRC="FIGDIR/small/438288v1_ufig1.gif" ALT="Figure 1"> View larger version (45K): org.highwire.dtl.DTLVardef@153428forg.highwire.dtl.DTLVardef@136ca5aorg.highwire.dtl.DTLVardef@1ee490org.highwire.dtl.DTLVardef@2fe478_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: proteomics
- assay: metagenomics
- research focus: host-pathogen & immune response
- research focus: variant effect prediction
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Naturally mutated spike proteins of SARS-CoV-2 variants show differential levels of cell entry
S. Ozono, Y. Zhang, … K. Tokunaga·Nature CommunicationsPeer-reviewed·Feb 8, 2021
- The Potential for SARS-CoV-2 to Evade Both Natural and Vaccine-induced Immunity
E. Shang, P. Axelsen·bioRxiv·Dec 13, 2020
- SARS-CoV-2 variant B.1.1.7 caused HLA-A2+ CD8+ T cell epitope mutations for impaired cellular immune response
C. Xiao, L. Mao, … G. Chen·iSciencePeer-reviewed·Mar 1, 2022
- Mutations of SARS-CoV-2 variants of concern escaping Spike-specific T cells
N. Le Bert, A. T. Tan, … A. Bertoletti·bioRxiv·Jan 20, 2022
- The P681H mutation in the Spike glycoprotein confers Type I interferon resistance in the SARS-CoV-2 alpha (B.1.1.7) variant
M. J. Lista, H. Winstone, … S. Neil·bioRxiv·Nov 9, 2021
- Nucleocapsid 203 mutations enhance SARS-CoV-2 immune evasion